ReviewCancers2020

Nivolumab plus Ipilimumab versus Existing Immunotherapies in Patients with PD-L1-Positive Advanced Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis.

Koichi Ando et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.